HARARE - The Medicines Control Authority of Zimbabwe on Monday announced the approval of the use of long-acting injectable cabotegravir (CAB-LA) as a pre-exposure prophylaxis (PrEP) for HIV prevention, a first for Africa. According to the World Health Organisation (WHO), "CAB-LA may be offered to people at substantial risk of HIV acquisition as part of…
Zimbabwe becomes first African country to approve use of injectable HIV prevention drug gnnliberia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gnnliberia.com Daily Mail and Mail on Sunday newspapers.